MENU
ORKA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Oruka Therapeutics (ORKA) Ownership - Who owns Oruka Therapeutics?
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
333.97M
P/E Ratio
N/A
Total Cash
410.88M
Projected Growth
N/A
Total Debt
988K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
10.97
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ORKA
Capitalization
334M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
411M
Total Cash/Share
10.97
Total Debt
988K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
N/A
Revenue
N/A
ROE
N/A
Book Value
339M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
35K
Current Ratio
22.89
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
663M
Shares Outstanding - Current
37.4M
Total Liabilities
71.7M
Total Volume MTD
N/A
Value
1
Gain YTD
-53.997
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information